🔗 Share this article

An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are urged to contact these accounts directly for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Some experts said the demand for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the service has removed problematic content and prohibited associated keywords and search suggestions. The company stated it was committed to keeping the service secure and investing in strengthening compliance measures.

Online Trading Operations

Investigations also found communities with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of users, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or injecting at home.

After minutes of entering one group, a seller shared WhatsApp details, where the majority of purchases take place. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.

Item Information and Costs

Inside these groups, posts display dark colored packages with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for Telegram stated it regularly monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they can’t verify. Even if the science behind this drug is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has already encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to potentially serious health risks”.